Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression

Inflammation

Volumn 36, Issue 6, 2013, Pages 1560-1566

  Ma, Zhanqiang ^a   Ji, Weiwei ^a   Fu, Qiang ^a   Ma, Shiping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

formononetin; inflammation; LPS induced acute lung injury; PPAR

Indexed keywords

DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FORMONONETIN; INTERLEUKIN 6; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG EDEMA; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PROTECTION;

ANIMALIA; MUS;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; EDEMA; INFLAMMATION; INTERLEUKIN-6; ISOFLAVONES; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; PEROXIDASE; PHYTOESTROGENS; PPAR GAMMA; PULMONARY EDEMA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888202075     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9700-5     Document Type: Article

References (23)

1. Kollef, M.H., and D.P. Schuster. 1995. The acute respiratory distress syndrome. The New England Journal of Medicine 332: 27-37.
2. Worthen, G.S., C. Haslett, A.J. Rees, R.S. Gumbay, J.E. Henson, and P.M. Henson. 1987. Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. The American Review of Respiratory Disease 136: 19-28.
3. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.
4. Berger, J., and D.E. Moller. 2002. The mechanisms of action of PPARs. Annual Review of Medicine 53: 409-435.
5. Denning, G.M., and L.L. Stoll. 2006. Peroxisome proliferator activated receptors: potential therapeutic targets in lung disease? Pediatric Pulmonology 41(1): 23-34.
6. Benayoun, L., S. Letuve, A. Druilhe, et al. 2001. Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. American Journal of Respiratory and Critical Care Medicine 164(8 I): 1487-1494.
7. Duez, H., J.C. Fruchart, and B. Staels. 2001. PPARs in inflammation, atherosclerosis and thrombosis. Journal of Cardiovascular Risk 8(4): 187-194.
8. Spinelli, S.L., J.J. O'Brien, and S. Bancos, et al. 2008. The PPAR platelet connection: modulators of inflammation and potential cardiovascular effects. PPAR Research vol. 2008, Article ID 328172, 16 pages.
9. Ameshima, S., H. Golpon, C.D. Cool, et al. 2003. Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circulation Research 92(10): 1162-1169.
10. Sinclair, S. 1998. Chinese herbs: a clinical review of Astragalus, Ligusticum, and Schizandrae. Alternative Medicine Review 3: 338-344.
11. Miller, A.L. 1998. Botanical influences on cardiovascular disease. Alternative Medicine Review 3: 422-431.
12. Tang, H.F., J.J. Lu, J.F. Tang, X. Zheng, Y.Q. Liang, X.F. Wang, et al. 2010. Action of a novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury. International Immunopharmacology 10(4): 406-411.
13. Valentina, P., C.L. Marchica, and M.S. Ludwig. 2009. Physiology &Neurobiology 169: 36-43.
14. Rubenfeld, G.D. 2003. Epidemiology of acute lung injury. Critical Care Medicine 31: 276-284.
15. Knapp, S., S. Florquin, D.T. Golenbock, and T. van der Poll. 2006. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. Journal of Immunology 176: 3189-3195.
16. Chen, H., C. Bai, and X. Wang. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Review of Respiratory Medicine 4: 773-783.
17. Cepkova, M., and M.A. Matthay. 2006. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. Journal of Intensive Care Medicine 21: 119-143.
18. Wang, Q., P. Teder, N.P. Judd, P.W. Noble, and C.M. Doerschuk. 2002. CD44 Deficiency leads to enhanced neutrophil migration and lung injury in escherichia coli pneumonia in mice. The American Journal of Pathology 161: 2219-2228.
19. Abraham, E. 2003. Neutrophils and acute lung injury. Critical Care Medicine 31: 195-199.
20. Klebanoff, S.J. 2005. Myeloperoxidase: friend and foe. Journal of Leukemia Biology 77: 598-625.
21. Chawla, A., Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 7: 48-52.
22. Kelly, D., J.I. Campbell, T.P. King, G. Grant, E.A. Jansson, A.G. Coutts, S. Pettersson, and S. Conway. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nature Immunology 5: 104-112.
23. Lee, C.H., A. Chawla, N. Urbiztondo, D. Liao, W.A. Boisvert, R.M. Evans, and L.K. Curtiss. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302: 453-457.